$BLUE: Glancy Prongay & Murray LLP Announces Investigation on Behalf of …

Date: Thursday, December 13th, 2018

Stock(s) mentioned:

Source: Business Wire (https://www.businesswire.com)

Summary: … on behalf of Bluebird Bio, Inc. investors (“Bluebird” or the “Company”) (NASDAQ: BLUE) concerning the Company and its officers’ possible violations of federal …

Full article address: https://www.businesswire.com/news/home/20181213005780/en/Glancy-Prongay-Murray-LLP-Announces-Investigation-Behalf

Related News:

$ALXN $ABBV $AIMT $BLUE: Top 5 New Drug Launches of 2019 — and the Biotech Stocks That …

$BLUE: bluebird bio to Present New Data from Clinical Studies of …

$BLUE $IBB: Bluebird Bio Shares Fall Over Analysts’ Concerns On Pricing Model

$BLUE: Downgrades rule in premarket analyst action

$BLUE: bluebird bio’s Analyst Day Highlights Commercial Path to Patients …

$BLUE: bluebird bio Flies Forward

$BLUE $CELG $REGN: bluebird’s (BLUE) Loss Wider Than Expected, Revenues Down Y/Y

$CELG $BLUE: Celgene Corporation and bluebird bio Announce Results from …

$BLUE: bluebird bio Appoints Joanne Smith-Farrell, Ph.D., to Chief Business …

$BLUE $ADRO $HUM $WCG: Is a Beat in Store for WellCare Health’s (WCG) Q1 Earnings?

$BLUE $ADRO $HUM $HCA: What’s in Store for HCA Healthcare’s (HCA) Q1 Earnings?

Latest News:

$GE: Is General Electric a Buy?

$HD $URBN: Home Depot, Target, HP, Best Buy and More Major Earnings …

$TMUS: Masayoshi Son: Genius or insane? Maybe neither

$DAL $ALK $LUV $NFLX $UAL: Delta’s test of free in-flight Wi-Fi may shame other airlines into offering service

$AVTR $FSLY $LK $LYFT $PINS $UBER: Why the IPO Boom Will Continue

$SBUX: Millions of Americans Could Miss Work Tomorrow After the ‘Game of Thrones’ Finale

$AMZN $OXY $APC $WFC $SRE: Want to invest like Warren Buffett? Here are the ins and outs of buying preferred stock

$TSLA $GM: Tesla fires could dampen electric car sales as industry ramps up EV production, auto analysts say

$ROKU $GH $CVNA: 3 Stocks That Have Doubled in 2019 — Are They Still Buys?

$AXSM: Here’s Why You’ll Regret Ignoring This Biotech Stock Rocket

$MMM: Market Loses Its Hopium-Induced High, Falls 4 Weeks Straight